-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Population-based studies on familial clustering of hematological malignancies (HM) rarely specifically focus on early-onset HM.
Recently, a research article was published in the British Journal of Haematology, an authoritative journal of blood system diseases.
Diagnosing lymphoma
The researchers identified a total of 8,791 patients diagnosed with primary HM from the Finnish Cancer Registry between 1970 and 2012, and their age was ≤40 years, and identified 75,774 family members of the patients from the population register.
Cumulative risk
In all the most common children , adolescents, and young adults (AYA) HM patients, the SIR of their first-degree relatives HM was elevated.
child
In conclusion, the significant increase in SIR of HM indicates that the cause is shared among some family members.
Significant increase in SIR of HM indicates that the cause is shared among some family members.
Original source:
Rosa Rönkkö.
org/10.
1111/bjh.
17477" target="_blank" rel="noopener">Familial aggregation of early-onset haematological malignancies
leave a message here
